CompletedNCT01451164
A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia
Researchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
Medication studyAges 18–65Japan
Understand this study
What did researchers investigate?
Researchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Kanto RegionSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateOctober 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 459
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Japan
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01451164
- Official title
Show the full official title
A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia
Recruitment & locations
CompletedKanto Region
Questions about this study
What did researchers investigate?
Researchers compared OPC-34712 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
Who is behind this study?
The study sponsor is Otsuka Pharmaceutical Co., Ltd., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including OPC-34712 and Placebo.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
A Clinical Pharmacology Trial of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses
A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia